Cargando…
New evidence-based adaptive clinical trial methods for optimally integrating predictive biomarkers into oncology clinical development programs
Predictive biomarkers are important to the future of oncology; they can be used to identify patient populations who will benefit from therapy, increase the value of cancer medicines, and decrease the size and cost of clinical trials while increasing their chance of success. But predictive biomarkers...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sun Yat-sen University Cancer Center
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845554/ https://www.ncbi.nlm.nih.gov/pubmed/23489587 http://dx.doi.org/10.5732/cjc.012.10248 |